Hydralazine as demethylating agent in breast cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics; Hydralazine
- Indications Breast cancer
- Focus Adverse reactions
- 04 Mar 2015 Biomarkers information updated
- 04 Dec 2008 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 02 Jun 2008 The expected completion date for this trial is now 1 Dec 2009 as reported by ClinicalTrials.gov.